Chief Financial Officer Shenouda Maged bought $843,990 worth of shares (200,000 units at $4.22), increasing direct ownership by 25% to 1,000,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RLMD· Relmada Therapeutics Inc.

Health Care

Original source

Chief Financial Officer Shenouda Maged bought $843,990 worth of shares (200,000 units at $4.22), increasing direct ownership by 25% to 1,000,000 units (SEC Form 4) | Quantisnow